MALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS: A COMPLICATION OF TAMOXIFEN THERAPY FOR BREAST CARCINOMA
DOI:
https://doi.org/10.7439/ijbar.v3i5.474Abstract
Patients with breast cancer exhibit an increased risk in developing neoplasms of other organs. In case of endometrium, the increased risk might be due to tamoxifen adjuvant therapy and prior radiotherapy. Carcinosarcomas are rare uterine cancers and carry poor prognosis. We present a case of Malignant Mixed Mullerian Tumor (MMMT) of the uterus in a 46-year-old woman, after tamoxifen treatment and radiotherapy for breast cancer. We emphasise thatDownloads
Download data is not yet available.
Downloads
Published
2012-06-01
Issue
Section
Case Report
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
MALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS: A COMPLICATION OF TAMOXIFEN THERAPY FOR BREAST CARCINOMA. (2012). International Journal of Biomedical and Advance Research, 3(5), 339-342. https://doi.org/10.7439/ijbar.v3i5.474
